Medicare Enrolled

Dr. Rehan Ahmad, D.O.

Endocrinology · Newburgh, NY
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Speaking/Promotional
5159 ROUTE 9W, Newburgh, NY 12550
8455615972
In practice since 2006 (19 years)
NPI: 1215959457 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Ahmad from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Ahmad? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Ahmad

Dr. Rehan Ahmad is an endocrinology specialist in Newburgh, NY, with 19 years of NPI registration. Based on federal Medicare data, Dr. Ahmad performed 3,368 Medicare services across 1,480 unique beneficiaries.

Between the years covered by Open Payments, Dr. Ahmad received a total of $102,032 from 53 pharmaceutical and/or device companies across 930 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in endocrinology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Ahmad is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 20% volume in NY $102,032 industry payments

Medicare Practice Summary

Medicare Utilization ↗
3,368
Medicare services
Top 20% in NY for endocrinology
1,480
Unique beneficiaries
$82
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~177 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
1,695 $98 $226
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
571 $67 $197
Continuous glucose monitoring with interpretation
This procedure involves monitoring blood sugar levels in tissue fluid using a sensor placed under the skin, along with the interpretation and reporting of the results.
468 $27 $116
Initial hospital admission, moderate complexity
Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter.
285 $111 $250
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
265 $68 $149
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
84 $127 $350
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$102,032
Total received (2018-2024)
Avg $14,576/year across 7 years
Top 6% in NY for endocrinology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
53
Companies
930
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$90,623 (88.8%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$11,409 (11.2%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$22,345
2023
$9,644
2022
$14,278
2021
$10,659
2020
$5,493
2019
$16,022
2018
$23,590

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Novo Nordisk Inc
$9,188
Dexcom, Inc.
$8,645
Abbott Laboratories
$2,859
Antares Pharma, Inc.
$364
Lilly USA, LLC
$323
Amgen Inc.
$143
Bayer Healthcare Pharmaceuticals Inc.
$96
ABBVIE INC.
$71
Amphastar Pharmaceuticals, Inc.
$68
Boehringer Ingelheim Pharmaceuticals, Inc.
$67
PFIZER INC.
$65
Insulet Corporation
$55
Verity Pharmaceuticals Inc.
$52
Medtronic, Inc.
$50
Ascendis Pharma Inc
$47
Corcept Therapeutics
$45
Xeris Pharmaceuticals, Inc.
$41
RECORDATI_RARE_DISEASES_INC.
$38
Amneal Pharmaceuticals LLC
$25
SANOFI-AVENTIS U.S. LLC
$23
Mannkind Corporation
$22
Radius Health, Inc.
$21
Ascensia Diabetes Care Us Inc.
$21
Tandem Diabetes Care, Inc.
$18
Top 3 companies account for 92.6% of 2024 payments
All-time payments by company (2018-2024) ›
Novo Nordisk Inc
$75,552
Dexcom, Inc.
$8,806
Abbott Laboratories
$7,077
Lilly USA, LLC
$1,719
Antares Pharma, Inc.
$1,127
Amgen Inc.
$958
Boehringer Ingelheim Pharmaceuticals, Inc.
$756
AstraZeneca Pharmaceuticals LP
$639
Corcept Therapeutics
$557
Insulet Corporation
$382
SANOFI-AVENTIS U.S. LLC
$378
Radius Health, Inc.
$329
AbbVie, Inc.
$245
Amneal Pharmaceuticals LLC
$227
Supernus Pharmaceuticals, Inc.
$206
Bayer HealthCare Pharmaceuticals Inc.
$202
Mannkind Corporation
$193
Bayer Healthcare Pharmaceuticals Inc.
$178
RECORDATI_RARE_DISEASES_INC.
$167
AbbVie Inc.
$154
Xeris Pharmaceuticals, Inc.
$150
Becton, Dickinson and Company
$147
Janssen Pharmaceuticals, Inc
$131
ABBVIE INC.
$128
Regeneron Healthcare Solutions, Inc.
$120
Amarin Pharma Inc.
$113
Amryt Pharma Holdings Ltd
$106
Merck Sharp & Dohme LLC
$101
Medtronic, Inc.
$100
PFIZER INC.
$98
Amphastar Pharmaceuticals, Inc.
$84
Horizon Therapeutics plc
$80
Acerus Pharmaceuticals Corporation
$69
Ascensia Diabetes Care Us Inc.
$65
Merck Sharp & Dohme Corporation
$52
Verity Pharmaceuticals Inc.
$52
Senseonics, Incorporated
$48
Ascendis Pharma Inc
$47
Tandem Diabetes Care, Inc.
$45
Ipsen Biopharmaceuticals, Inc
$45
Clarus Therapeutics Inc.
$43
EUSA Pharma (US) LLC
$42
Currax Pharmaceuticals LLC
$41
Shire North American Group Inc
$39
IBSA Pharma Inc.
$37
Medtronic MiniMed, Inc.
$37
Kowa Pharmaceuticals America, Inc.
$34
Valeritas, Inc.
$25
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$24
MannKind Corporation
$21
Embecta Corp.
$21
Boston Scientific Corporation
$20
Intuity Medical Inc
$18
Top 3 companies account for 89.6% of all-time payments
Associated products mentioned in payments ›
AFREZZA · Androgel · BAQSIMI · BD Nano · BD Nano 2nd Gen Pen Needle · CONTRAVE · CYCLOSET · Corlanor · DEXCOM CGM · DEXCOM G7 GSS (161) · Dexcom CGM · EVENITY · EVERSENSE E3 SENSOR KIT - RETAIL · EVERSENSE E3 SMART TRANSMITTER KIT · Eversense · FARXIGA · FORTEO · FREESTYLE INSULINX · FREESTYLE LIBRE · FREESTYLE LIBRE 3 · FreeStyle Libre · FreeStyle Libre blood glucose Flash Monitoring System · GVOKE HYPOPEN · GVOKE PFS · General - Pain Management · HUMULIN · INVOKANA · ISTURISA · JANUVIA · JARDIANCE · JATENZO · Kerendia · Korlym · Livalo · MINIMED 770G · MINIMED 780G · MOUNJARO · MYCAPSSA · Minimed 630G · Minimed 670G System · NATPARA · NOCDURNA · Natesto · OTREXUP · Omnipod · Otrexup · Ozempic · PRALUENT · PRALUENT ALIROCUMAB INJECTION · PREVNAR 20 · Pogo Automatic Blood Glucose Monitoring System · Prolia · RECORLEV · RYBELSUS · Repatha · Rybelsus · SIGNIFOR LAR · SOMATULINE DEPOT · SOMAVERT · STEGLATRO · SYNJARDY · SYNTHROID · Saxenda · Somatuline Depot · Sylvant · Synthroid · TEPEZZA · TOUJEO · TRADJENTA · TRULICITY · TZIELD · Tirosint · Tlando · Tresiba · Tymlos · UNITHROID · V-GO · Vascepa · Victoza · Wegovy · XARELTO · XYOSTED · ZEPBOUND · t:slim X2 Insulin Pump with Control-IQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (89%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in endocrinology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 6% for endocrinology in NY.

Looking for an endocrinology specialist in Newburgh?
Compare endocrinologists in the Newburgh area by procedure volume, costs, and industry payment transparency.
Browse endocrinologists nearby

Geographic Context

Endocrinologists within 10 mi
30
Per 100K population
7.4
County median income
$96,497
Nearest hospital
MONTEFIORE ST LUKE'S CORNWALL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Ahmad is a clinical cardiology specialist, with above-average Medicare volume (top 20% in NY), with speaking/promotional industry engagement in the top 6% of NY peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Ahmad experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Ahmad performed 1,695 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Ahmad receive payments from pharmaceutical companies?
Yes. Dr. Ahmad received a total of $102,032 from 53 companies across 930 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Ahmad's costs compare to other endocrinologists in Newburgh?
Dr. Ahmad's average Medicare payment per service is $82. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Ahmad) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →